Correlation Between Eledon Pharmaceuticals and Organon

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eledon Pharmaceuticals and Organon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eledon Pharmaceuticals and Organon into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eledon Pharmaceuticals and Organon Co, you can compare the effects of market volatilities on Eledon Pharmaceuticals and Organon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eledon Pharmaceuticals with a short position of Organon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eledon Pharmaceuticals and Organon.

Diversification Opportunities for Eledon Pharmaceuticals and Organon

-0.78
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Eledon and Organon is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Eledon Pharmaceuticals and Organon Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Organon and Eledon Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eledon Pharmaceuticals are associated (or correlated) with Organon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Organon has no effect on the direction of Eledon Pharmaceuticals i.e., Eledon Pharmaceuticals and Organon go up and down completely randomly.

Pair Corralation between Eledon Pharmaceuticals and Organon

Given the investment horizon of 90 days Eledon Pharmaceuticals is expected to generate 2.11 times more return on investment than Organon. However, Eledon Pharmaceuticals is 2.11 times more volatile than Organon Co. It trades about 0.05 of its potential returns per unit of risk. Organon Co is currently generating about -0.03 per unit of risk. If you would invest  245.00  in Eledon Pharmaceuticals on September 13, 2024 and sell it today you would earn a total of  201.00  from holding Eledon Pharmaceuticals or generate 82.04% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy99.8%
ValuesDaily Returns

Eledon Pharmaceuticals  vs.  Organon Co

 Performance 
       Timeline  
Eledon Pharmaceuticals 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Eledon Pharmaceuticals are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of very weak fundamental indicators, Eledon Pharmaceuticals displayed solid returns over the last few months and may actually be approaching a breakup point.
Organon 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Organon Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of sluggish performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Eledon Pharmaceuticals and Organon Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eledon Pharmaceuticals and Organon

The main advantage of trading using opposite Eledon Pharmaceuticals and Organon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eledon Pharmaceuticals position performs unexpectedly, Organon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organon will offset losses from the drop in Organon's long position.
The idea behind Eledon Pharmaceuticals and Organon Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities